𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia implication for lipoprotein(a) metabolism

✍ Scribed by Lindahl, G. ;Mailly, F. ;Humphries, S. ;Seed, M.

Publisher
Springer-Verlag
Year
1994
Tongue
English
Weight
803 KB
Volume
72
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Apolipoprotein(a) phenotypes and lipopro
Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with hyperthyroidism
✍ I. C. Klausen; L. HegedΓΌs; P. S. Hansen; F. E. Nielsen; L. U. Gerdes; O. Faergem πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 544 KB

Lipoprotein(a) [Lp(a)] is a low-density lipoprotein (LDL) particle in which apolipoprotein B-100 (apoB) is attached to a glycoprotein called apolipoprotein(a) [apo(a)]. Apo(a) has several genetically determined phenotypes differing in molecular weight, to which Lp(a) concentrations in plasma are inv

Lack of evidence for linkage between low
Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia
✍ Melissa A. Austin; Ellen Wijsman; Sunwei Guo; Ronald M. Krauss; John D. Brunzell πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 691 KB

Low-density lipoprotein (LDL) subclass phenotype B, characterized by a predominance of small, dense LDL particles, appears to be a genetically influenced risk factor for coronary heart disease. Phenotype B, as determined by gradient gel electrophoresis, appears to be inherited in a manner consistent

Association of elevated lipoprotein(a) l
Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes
✍ J. Ruiz; J. Thillet; T. Huby; R. W. James; D. Erlich; P. Flandre; P. Froguel; J. πŸ“‚ Article πŸ“… 1994 πŸ› Springer 🌐 English βš– 824 KB

Non-insulin-dependent diabetes mellitus (NIDDM) is a strong and independent risk factor for cardiovascular and coronary heart disease mortality [1]. Established risk factors, including glucose intolerance, arterial hypertension, central obesity, hypercholesterolaemia or hypertriglyceridaemia, have b